World Biosimilar Sector Developments Traced by FirstWord in New Report …PR Web (press release)The leading amid the biosimilar and NCB development league is Rituximab (Rituxan/MabThera; Roche), possessing more than 30 individual programmes worldwide. …
Dedicated Deep Bay biker – Parksville Qualicum Beach News
|
Dedicated Deep Bay biker
Parksville Qualicum Beach News He had a stem cell transplant about six months after his diagnoses in May 2011 but the results weren’t what he was hoping for. His chemotherapy pills will eventually stop working, he said, but thanks to research a new drug called Pomalist recently hit … |
Hypernatremia Linked to Post-Liver Transplant Mortality – Doctors Lounge
Hypernatremia Linked to Post-Liver Transplant MortalityDoctors LoungeTUESDAY, April 8, 2014 (HealthDay News) — Pre-liver transplant (LTx) hyponatremia does not affect post-LTx survival, but hypernatremia is a significant risk factor for post-LTx morta…
Quad bike tragedy boy Ultan Hayes saved four lives through organ donation – Irish Mirror
Irish Mirror |
Quad bike tragedy boy Ultan Hayes saved four lives through organ donation
Irish Mirror Tragic schoolboy Ultan Hayes has saved four lives after his organs were donated, his funeral has heard today. Heartbroken mourners were told that even in death, the little Ultan has given life – three of the recipients were children. Ultan’s devastated … |
First-in-Class Drug Shows Activity in Advanced Blood Cancers – Medscape
Medscape |
First-in-Class Drug Shows Activity in Advanced Blood Cancers
Medscape Some of the patients in the study had relapsed after bone marrow transplantation; in these patients, survival is typically very poor, he explained. “These are extremely exciting results.” The primary goal of this phase 1 study was to determine the … |
Growing noses, growing science? UK campaign to attract research cites lab … – U.S. News & World Report
|
Growing noses, growing science? UK campaign to attract research cites lab …
U.S. News & World Report Later this year, a trial is scheduled to start in India and London to test lab-made ears for people born without them. “Ears are harder to make than noses because you have to get all the … “Scientists have to get things like noses and ears right … |
Gilead aims to license hepatitis C drug to 3-4 Indian firms – Reuters India
The Pharma Letter |
Gilead aims to license hepatitis C drug to 3-4 Indian firms
Reuters India We’re nailing down the geographical scope, and we should have these licences in place and ready to go in short order,” Samuel said on a visit to London for an international liver conference. He said Gilead was looking to strike deals with firms that … WHO Calls For ‘Concerted Effort’ To Bring Down Hepatitis C Drug CostsHuffington Post WHO joins clamor to make new Hepatitis C pills affordableGMA News |
Gilead aims to license hepatitis C drug to 3-4 Indian firms – WTAQ
|
Gilead aims to license hepatitis C drug to 3-4 Indian firms
WTAQ We’re nailing down the geographical scope, and we should have these licenses in place and ready to go in short order,” Samuel said on a visit to London for an international liver conference. He said Gilead was looking to strike deals with firms that … |
Managing chronic kidney disease in primary care: a practice guide for practice … – Nursing in Practice
|
Managing chronic kidney disease in primary care: a practice guide for practice …
Nursing in Practice Chronic kidney disease is defined as irreversible kidney damage leading to structural abnormality with proteinuria and/or haematuria, and/or glomerular filtration rate (GFR) <60ml/min/1.73m².1 Glomerular filtration rate describes the flow rate of … |
UK scientists making body parts in the lab – Boston Globe
Boston Globe |
UK scientists making body parts in the lab
Boston Globe Later this year, a trial is scheduled to start in India and London to test lab-made ears for people born without them. ”Ears are harder to make than noses because you have to get all … ”Scientists have to get things like noses and ears right before … |